Q1 2025 Cencora Inc Earnings Call Transcript
Key Points
- Cencora Inc (COR) reported a strong start to fiscal year 2025 with a 13% increase in revenue and a 14% growth in adjusted EPS.
- The company raised its full-year guidance due to strong execution in its US business, highlighting its leadership in healthcare solutions.
- Cencora Inc (COR) completed the acquisition of Retina Consultants of America, enhancing its position in the specialty market.
- The company is driving efficiency and productivity through advanced technology and expert teams, aligning with its digital transformation strategy.
- Cencora Inc (COR) is focusing on a customer-centric approach, collaborating with customers to innovate and meet evolving needs, demonstrated by its inaugural product showcase.
- Consolidated gross profit margin decreased by 20 basis points due to increased sales of low-margin GLP-1 products and lower sales of COVID-19 vaccines.
- The International Healthcare Solutions segment saw a 3% decline in operating income on an as-reported basis, attributed to subdued clinical trial activity.
- Cencora Inc (COR) faces a significant headwind from lower sales of COVID-19 vaccines, with no expected contribution in the second quarter of fiscal 2025.
- The company anticipates higher net interest expenses due to the financing of the RCA acquisition, impacting fiscal year 2025.
- The International Healthcare Solutions segment's revenue growth guidance was lowered due to updated foreign currency translation rates.
Hello, and welcome, everyone, to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky, and I'll be your operator today. (Operator Instructions)
I will now hand over to your host, Head of Investor Relations, Bennett Murphy, to begin. Please go ahead.
Thank you. Good morning, good afternoon, and thank you all for joining us for this conference call to discuss Cencora's fiscal 2025 first quarter results. I am Bennett Murphy, Senior Vice President, Head of Investor Relations and Treasury. Joining me today are Bob Mauch, President and CEO; and Jim Cleary, Executive Vice President and CFO.
On today's call, we will be discussing non-GAAP financial measures. Reconciliations of these measures to GAAP are provided in today's press release, which is available on our website at investor.cencora.com. We have also posted a slide presentation to accompany today's press release on our investor website.
During this conference call, we will make forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
